PIM
ALT icon

Platinum Investment Management’s Altimmune ALT Stock Holding History

Platinum Investment Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-95,081
Closed -$247K – 143
2023
Q3 		$247K Hold
95,081
– – 0.01% 102
2023
Q2 		$336K Hold
95,081
– – 0.01% 107
2023
Q1 		$401K Sell
95,081
-23,649
-20% -$281K 0.01% 110
2022
Q4 		$1.95M Hold
118,730
– – 0.07% 79
2022
Q3 		$1.52M Buy
118,730
+61,867
+109% +$913K 0.06% 86
2022
Q2 		$665K Buy
+56,863
New +$351K 0.03% 105

Other funds holding ALT

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return

Platinum Investment Management's ALT Position: Q4 2023 in Review

Platinum Investment Management sold out of Altimmune (ALT) in Q4 2023, closing a stake of 95,081 shares — an estimated $247K sold.

Platinum Investment Management first reported a position in ALT in Q2 2022 and held it in 6 quarters. The position peaked at $1.95M in Q4 2022. 143 funds tracked by Wall St. Rank hold ALT as of Q4 2023.

  • Platinum Investment Management reported no remaining Altimmune position as of Q4 2023 after selling out during the quarter.
  • Platinum Investment Management sold 95,081 Altimmune shares in Q4 2023, an estimated $247K.
  • Platinum Investment Management first reported a position in Altimmune in Q2 2022 and held it in 6 quarters.
  • Platinum Investment Management's Altimmune position peaked at $1.95M in Q4 2022.
  • 143 funds tracked by Wall St. Rank held Altimmune as of Q4 2023.

Based on Platinum Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.